Диссертация (1140821), страница 22
Текст из файла (страница 22)
ObstetGynecol Surv. 2006;61:59-69; quiz 70-72.107.James AH, Brancazio LR, Ortel TL. Thrombosis, thrombophilia, andthromboprophylaxis in pregnancy. Clin Adv Hematol Oncol. 2005;3:187-197.108.James AH, Jamison MG, Brancazio LR, et al. Venous thromboembolismduring pregnancy and the postpartum period: incidence, risk factors, and mortality. AmJ Obstet Gynecol. 2006;194:1311-1315.109.James AH, Konkle BA, Bauer KA. Prevention and treatment of venousthromboembolism in pregnancy in patients with hereditary antithrombin deficiency.
IntJ Womens Health. 2013 May 3;5:233-41.110.James AH, Tapson VF, Goldhaber SZ. Thrombosis during pregnancy andthe postpartum period. Am J Obstet Gynecol. 2005;193:216-219.111.Jara LJ, Medina G, Vera-Lastra O. Systemic antiphospholipid syndromeand atherosclerosis. Clin Rev Allergy Immunol. 2007 Apr;32(2):172-7.142Jones112.HN, Jansson T, Powell TL.
IL-6 stimulates system A amino acid transporter activity introphoblast cells through STAT3 and increased expression of SNAT2. Am J Physiol CellPhysiol. 2009; 297 (5):C1228–C1235.Kaiser113.PS, Kirby RS, Obesity as a risk factor for cesarean in a low-risk population. ObstetGynecol. 2001, 97: 39-43.114.Kato H., Kashiwagi H., Shiraga M. et al.
Adiponectin acts as an endogenousantithrombotic factor. Arterioscler Thromb Vase Biol. 2006; 26: 224-230.115.Khan IY, Dekou V, Douglas G, et al. A high-fat diet during rat pregnancyor suckling induces cardiovascular dysfunction in adult offspring. Am J Physiol RegulIntegr Comp Physiol. 2005; 288(1):R127–R133.116.Khan IY, Taylor PD, Dekou V, et al. Gender-linked hypertension inoffspring of lard-fed pregnant rats. Hypertension. 2003; 41(1):168–175.117.Kidron D, Bernheim J, Aviram R.
Placental findings contributing to fetaldeath, a study of 120 stillbirths between 23 and 40 weeks gestation. Placenta. 2009;30(8):700–704.118.Kim JA, Montagnani M, Koh KK & Quon MJ. Reciprocal relationshipsbetween insulin resistance and endothelial dysfunction: molecular andpathophysiological mechanisms. Circulation 2006 113 1888–1904.119.Kobashi G, Ohta K, Yamada H, Hata A, Minakami H, Sakuragi N,Tamashiro H, Fujimoto S; Hokkaido. 4G/5G variant of plasminogen activator inhibitor-1gene and severe pregnancy-induced hypertension: subgroup analyses of variants ofangiotensinogen and endothelial nitric oxide synthase.
J Epidemiol. 2009;19(6):275-80.120.Kopp C.W., Kopp H.P., Steiner S. et al. Weight loss reduces tissue factor inmorbidly obese patients. Obes Res. 2003; 11: 950-956.121.Kotronen A, Yki-Ja¨rvinen H. Fatty liver: a novel component of themetabolic syndrome. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 27–38.143122.Kovacevich GJ, Gaich SA, Lavin JP, et al.
The prevalence ofthromboembolic events among women with extended bed rest prescribed as part of thetreatment for premature labor or preterm premature rupture of membranes. Am J ObstetGynecol. 2000;182:1089-1092.123.Kristensen J, Vestergaard M, Wisborg K, Kesmodel U, Secher NJ. Pre-pregnancy weight and the risk of stillbirth and neonatal death. BJOG. 2005; 112(4):403–408.124.Laine PS, Schwartz EA, Wang Y, et al. Palmitic acid induces IP-10expression in human macrophages via NF-kappaB activation. Biochem Biophys ResCommun.
2007; 358(1):150–155.125.Lakshmy R. Metabolic syndrome: Role of maternal undernutrition and fetalprogramming. Rev Endocr Metab Disord. 2013 Sep;14(3):229-40.126.Le Gal G, Righini M. J . Controversies in the diagnosis of venousthromboembolism. Thromb Haemost. 2015 Jun; 13 Suppl 1:S259-65.127.Lee JY, Sohn KH, Rhee SH, Hwang D.
Saturated fatty acids, but notunsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated throughToll-like receptor 4. J Biol Chem. 2001; 276 (20):16683–16689.128.Leila M, Ariane R, Maria S, Claudia B. Metabolic syndrome components inarterial hypertension. Rev Esc Enferm USP. 2012; 46(6):1349-54.129.Lepercq J, Conard J, Borel-Derlon A, et al. Venous thromboembolismduring pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies.
BJOG.2001;108:1134-1140.130.Li H & Forstermann U. Nitric oxide in the pathogenesis of vascular disease.Journal of Pathology 2000 190 244–254.131.Libby P., Ridker P.M., Hansson G.K. Progress and challenges in translatingthe biology of atherosclerosis. Nature. 2011; 473: 317-325.132.Lijnen H., Collen D. Molecular and cellular basis of fibrinolysis.
In:Hoffman R. Benz E.J., Shattil S.J., Furie В. et al. (eds). Elsevier: Philadelphia. 2005.144133.Lim W. Antiphospholipid antibody syndrome. Hematology Am SocHematol Educ Program. 2009:233-9.134.Lindqvist P, Dahlback B, Marsal K. Thrombotic risk during pregnancy: apopulation study. Obstet Gynecol. 1999;94:595-599.135.Linnemann B, Bauersachs R, Rott H, Halimeh S, Zotz R, Gerhardt A,Boddenberg-Pätzold B, Toth B, Scholz U, Working Group in Women's Health of theSociety of Thrombosis and Haemostasis.
Diagnosis of pregnancy-associated venousthromboembolism - position paper of the Working Group in Women's Health of theSociety of Thrombosis and Haemostasis (GTH). Vasa. 2016; 45(2):87-101.136.Linnemann B, Scholz U, Rott H, Halimeh S3, Zotz R, Gerhardt A, TothB6, Bauersachs R; Working Group in Women's Health of the Society of Thrombosisand Hemostasis. Treatment of pregnancy-associated venous thromboembolism position paper from the Working Group in Women's Health of the Society ofThrombosis and Haemostasis (GTH). Vasa.
2016;45(2):103-18.137.Livadas S, Diamanti-Kandarakis E. Polycystic ovary syndrome: definitions,phenotypes and diagnostic approach. Front Horm Res. 2013;40:1-21.138.Lumeng C.N., Bodzin J.L., Saltiel A.R. Obesity induces a phenotypicswitch in adipose tissue macrophage polarization. J Clin Invest. 2007; 117: 175-184.139.Lumeng CN, Saltiel AR.
Inflammatory links between obesity and metabolicdisease. J Clin Invest. 2011; 121(6):2111–2117.140.Macklon NS, Greer IA, Bowman AW. An ultrasound study of gestationaland postural changes in the deep venous system of the leg in pregnancy. Br J ObstetGynaecol. 1997;104:191-197.141.Madan JC, Davis JM, Craig WY, et al.
Maternal obesity and markers ofinflammation in pregnancy. Cytokine. 2009; 47(1):61–64.142.Mark PJ, Sisala C, Connor K, et al. A maternal high-fat diet in ratpregnancy reduces growth of the fetus and placental junctional zone, but not placentallabyrinth zone growth. J Dev Origins Health Dis. 2011; 2(1):63–70.145143.Mattu H.S., Randeva H.S. The role of adipokines in cardiovascular disease.J Endocrinol. 2013; 216: 17-3.144.Maury E., Brichard S.M. Adipokine dysregulation, adipose tissueinflammation and metabolic syndrome. Mol Cell Endocrinol.
2010; 314:1-16.145.Meade T.W., Ruddock V., Stirling Y. et al. Fibrinolytic activity, clottingfactors, and long-term incidence of ischaemic heart disease in the Northwick Park HeartStudy. Lancet. 1993; 342: 1076-1079.146.Meenakshi, Srivastava R, Sharma NR, Kushwaha KP, Aditya V. ObstetricBehavior and Pregnancy Outcome in Overweight and Obese Women. The Journal ofObstetrics and Gynecology of India 2012 62(3):276–280.147.Mierla D, Szmal C, Neagos D, Cretu R, Stoian V, Jardan D.
Association ofProthrombin (A20210G) and Factor V Leiden (A506G) with Recurrent Pregnancy Loss.Maedica (Buchar). 2012 Sep;7(3):222-6.148.Mina A, Favaloro EJ & Koutts J. Hemostatic dysfunction associated withendocrine disorders as a major risk factor and cause of human morbidity and mortality: acomprehensive meta-review. Seminars in Thrombosis and Hemostasis 2007 33 798–809.149.Mojtabai R.
Body mass index and serum folate in childbearing women. EurJ Epidemiol 2004;19:1029-36.150.Molins В., Pena E., de la Torre R., Badimon L. Monomeric C-reactiveprotein is prothrombotic and dissociates from circulating pentameric C-reactive proteinon adhered activated platelets under flow. Cardiovasc Res. 2011; 92: 328-337.151.Mottillo S., Filion K.B., Genest J. et al. The metabolic syndrome andcardiovascular risk a systematic review and meta-analysis. Am Coll Cardiol. 2010; 56:1113-1132.152.Murakami T., Horigome H., Tanaka K.
et al. Impact of weight reduction onproduction of platelet-derived microparticles and fibrinolytic parameters in obesity.Thromb Res. 2007; 119: 45-53.153.Nagai N., Hoylaerts M.F., Cleuren A.C. et al. Obesity promotes injuryinduced femoral artery thrombosis in mice. Thromb Res. 2008; 122: 549-555.146154.Napoleone E., Ai D.I., Amore С et al. Leptin induces tissue factorexpression in human peripheral blood mononuclear cells: a possibledink between obesityand cardiovascular risk? J Thromb Haemost. 2007; 5: 1462-1468.155.Natal C., Restituto P., Inigo С. et al. The proinflam- matory mediator CD40ligand is increased in the metabolic syndrome and modulated by adiponec- tin.
J ClinEndocrinol Metab. 2008; 93: 2319-2327.156.Neville C, Rauch J, Kassis J, Chang ER, Joseph L, Le Comte M, Fortin PR.Thromboembolic risk in patients with high titre anticardiolipin and multipleantiphospholipid antibodies. Thromb Haemost. 2003 Jul;90(1):108-15.157.Nguyen MT, Favelyukis S, Nguyen AK, et al. A subpopulation ofmacrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acidsvia Toll-like receptors 2 and 4 and JNK-dependent pathways.















